Another potential mechanism of R-CHOP resistance in DLBCL, cell adhesion-mediated drug resistance (CAM-DR), is also correlated with dysregulated PI3K-Akt signaling (48, 49). The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.